Browse > Article
http://dx.doi.org/10.5483/BMBRep.2021.54.11.089

Neuromedin B modulates phosphate-induced vascular calcification  

Park, Hyun-Joo (Department of Oral Physiology, School of Dentistry, Pusan National University)
Kim, Mi-Kyoung (Department of Oral Physiology, School of Dentistry, Pusan National University)
Kim, Yeon (Department of Oral Physiology, School of Dentistry, Pusan National University)
Kim, Hyung Joon (Department of Oral Physiology, School of Dentistry, Pusan National University)
Bae, Soo-Kyung (Periodontal Disease Signaling Network Research Center (MRC), School of Dentistry, Pusan National University)
Bae, Moon-Kyoung (Department of Oral Physiology, School of Dentistry, Pusan National University)
Publication Information
BMB Reports / v.54, no.11, 2021 , pp. 569-574 More about this Journal
Abstract
Vascular calcification is the heterotopic accumulation of calcium phosphate salts in the vascular tissue and is highly correlated with increased cardiovascular morbidity and mortality. In this study, we found that the expression of neuromedin B (NMB) and NMB receptor is upregulated in phosphate-induced calcification of vascular smooth muscle cells (VSMCs). Silencing of NMB or treatment with NMB receptor antagonist, PD168368, inhibited the phosphate-induced osteogenic differentiation of VSMCs by inhibiting Wnt/β-catenin signaling and VSMC apoptosis. PD168368 also attenuated the arterial calcification in cultured aortic rings and in a rat model of chronic kidney disease. The results of this study suggest that NMB-NMB receptor axis may have potential therapeutic value in the diagnosis and treatment of vascular calcification.
Keywords
Bombesin-like peptides; Neuromedin B; Neuromedin B receptor; Vascular calcification; Vascular smooth muscle cells;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Majumdar ID and Weber HC (2011) Biology of mammalian bombesin-like peptides and their receptors. Curr Opin Endocrinol Diabetes Obes 18, 68-74   DOI
2 Choi Y, Heo SC, Kim YN et al (2020) Gastrin-releasing peptide (GRP) stimulates osteoclastogenesis in periodontitis. Cells 10, 50   DOI
3 Yeo CE, Kang WY, Seong SJ et al (2017) Neuromedin B and its receptor silencing suppresses osteoclast generation by modulating precursor proliferation via M-CSF/c-Fms/D-type cyclins. Exp Cell Res 359, 112-119   DOI
4 Cannata-Andia JB, Roman-Garcia P, and Hruska K (2011) The connections between vascular calcification and bone health. Nephrol Dial Transplant 26, 3429-3436   DOI
5 Gonzalez N, Mantey SA, Pradhan TK et al (2009) Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors. Peptides 30, 1473-1486   DOI
6 Jensen RT, Battey JF, Spindel ER, and Benya RV (2008) International union of pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 60, 1-42   DOI
7 Cai T, Sun D, Duan Y et al (2016) WNT/beta-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression. Exp Cell Res 345, 206-217   DOI
8 Akiyoshi T, Ota H, Iijima K et al (2016) A novel organ culture model of aorta for vascular calcification. Atherosclerosis 244, 51-58   DOI
9 McCarty MF and DiNicolantonio JJ (2014) The molecular biology and pathophysiology of vascular calcification. Postgrad Med 126, 54-64   DOI
10 Johnson RC, Leopold JA, and Loscalzo J (2006) Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99, 1044-1059   DOI
11 Wu D and Pan W (2010) GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem Sci 35, 161-168   DOI
12 Gonzalez N, Moody TW, Igarashi H, Ito T, and Jensen RT (2008) Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states. Curr Opin Endocrinol Diabetes Obes 15, 58-64   DOI
13 Saito H, Nakamachi T, Inoue K et al (2013) Autocrine effects of neuromedin B stimulate the proliferation of rat primary osteoblasts. J Endocrinol 217, 141-150   DOI
14 Jono S, McKee MD, Murry CE et al (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87, E10-7
15 Shobeiri N, Adams MA, and Holden RM (2010) Vascular calcification in animal models of CKD: A review. Am J Nephrol 31, 471-481   DOI
16 Park HJ, Kim MK, Kim Y et al (2017) Gastrin-releasing peptide promotes the migration of vascular smooth muscle cells through upregulation of matrix metalloproteinase-2 and -9. BMB Rep 50, 628-633   DOI
17 Martinez A, Zudaire E, Julian M, Moody TW, and Cuttitta F (2005) Gastrin-releasing peptide (GRP) induces angiogenesis and the specific GRP blocker 77427 inhibits tumor growth in vitro and in vivo. Oncogene 24, 4106-4113   DOI
18 Song WJ, Song EA, Jung MS et al (2015) Phosphorylation and inactivation of glycogen synthase kinase 3beta (GSK3beta) by dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A). J Biol Chem 290, 2321-2333   DOI
19 Tamagaki K, Yuan Q, Ohkawa H et al (2006) Severe hyper-parathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia. Nephrol Dial Transplant 21, 651-659   DOI
20 Park HJ, Kim SR, Bae SK et al (2009) Neuromedin B induces angiogenesis via activation of ERK and Akt in endothelial cells. Exp Cell Res 315, 3359-3369   DOI
21 Cong J, Cheng B, Liu J, and He P (2021) RTEF-1 inhibits vascular smooth muscle cell calcification through regulating Wnt/beta-Catenin signaling pathway. Calcif Tissue Int 109, 203-214   DOI
22 Kim MK, Park HJ, Kim Y, Kim HJ, Bae SK, and Bae MK (2017) Gastrin-releasing peptide induces monocyte adhesion to vascular endothelium by upregulating endothelial adhesion molecules. Biochem Biophys Res Commun 485, 542-549   DOI
23 Rodriguez-Granillo GA, Carrascosa P, and Bruining N (2016) Progression of coronary artery calcification at the crossroads: sign of progression or stabilization of coronary atherosclerosis? Cardiovasc Diagn Ther 6, 250-258   DOI
24 Park HJ, Kim Y, Kim MK et al (2020) Inhibition of gastrin-releasing peptide attenuates phosphate-induced vascular calcification. Cells 9, 737   DOI
25 Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, and Weissberg PL (2000) Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 87, 1055-1062   DOI
26 Znorko B, Oksztulska-Kolanek E, Michalowska M, Kaminski T, and Pawlak K (2017) Does the OPG/RANKL system contribute to the bone-vascular axis in chronic kidney disease? A systematic review. Adv Med Sci 62, 52-64   DOI
27 Dai Z, Zhu J, Huang H et al (2020) Expression and clinical value of gastrin-releasing peptide precursor in nephropathy and chronic kidney disease. Nephrology (Carlton) 25, 398-405   DOI
28 Evenepoel P, Opdebeeck B, David K, and D'Haese PC (2019) Bone-vascular axis in chronic kidney disease. Adv Chronic Kidney Dis 26, 472-483   DOI
29 Leopold JA (2015) Vascular calcification: mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med 25, 267-274   DOI
30 Singh A, Tandon S, and Tandon C (2021) An update on vascular calcification and potential therapeutics. Mol Biol Rep 48, 887-896   DOI
31 Schlieper G, Schurgers L, Brandenburg V, Reutelingsperger C, and Floege J (2016) Vascular calcification in chronic kidney disease: an update. Nephrol Dial Transplant 31, 31-39   DOI